Pricing Log in Create free account

Gain Therapeutics, Inc. (GANX) vs LeonaBio, Inc. (LONA)

Gain Therapeutics, Inc. and LeonaBio, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and LeonaBio, Inc. are of similar size ($41.9M and $40.9M). Across the 9 metrics below, Gain Therapeutics, Inc. leads on 5 and LeonaBio, Inc. on 4.

Valuation

Metric GANX LONA Biotechnology median
P/E n/m n/m 10.60
P/S 219.56 n/m 9.40
P/B 3.80 3.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 154.32 n/m 9.02
Earnings yield (50.00%) (522.84%) (32.88%)
Free cash flow yield (44.25%) (59.08%) (23.13%)

Profitability

Metric GANX LONA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (268.30%) (431.39%) (51.96%)
Return on assets (159.22%) (306.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GANX LONA Biotechnology median
Revenue growth (TTM) 18.36% — 6.76%
EPS growth (last fiscal year) 31.46% 1.98% 29.88%
Revenue growth, 5-year CAGR 21.79% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GANX LONA Biotechnology median
Debt to equity 0.03 0.00 0.00
Current ratio 4.36 7.01 4.97
Net debt to EBITDA 1.10 0.87 1.01

Dividend

Metric GANX LONA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GANX LONA Biotechnology median
Market cap 41.91m 40.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack